- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04493736
CAMPUS Expanded "Classification and Assessment of Mental Health Performance Using Semantics Expanded" (CAMPUS-E)
February 5, 2024 updated by: Clarigent Health
Open enrollment study to collect data for the optimization of machine learning models for use in an app for the early detection of mental health and suicidal risk.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Mason, Ohio, United States, 45040
- Recruiting
- Clarigent Health
-
Contact:
- Clarigent Research
- Phone Number: 513-445-3022
- Email: research@clarigenthealth.com
-
Contact:
- Joshua I Cohen, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 75 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
The study employs a cohort design, using open and rolling recruitment of MHP participants at multiple locationssites nationally.
We will recruit from mental health therapy practices, schools (using school based MHPs), community mental health agencies, or colleges/universities (counseling centers).
Participating MHPs will begin enrolling client participants after completing the online protocol training and brief human subject's protection training.
Recruitment will continue on a rolling basis until 2000 client participants have been enrolled and 6000 sessions have been recorded.
Description
Inclusion Criteria:
- Currently a client receiving services from a MHP at a school or outpatient setting, or at a college/university counseling center
- Age ≥ 8 years old
- Able to provide informed consent, parental permission or assent
- English as a primary language
Exclusion Criteria:
- Participants with communication disorders (linguistic or articulation)
- Any minor participants for whom parental or legal guardian consent cannot be obtained.
- Any adult participant for whom Legal Authorized Representative (LAR) consent cannot be obtained.
- History of any other serious medical or psychiatric condition that would interfere with the ability of the patient to complete the study or would make it ethically unfeasible to enroll them
- Participants with an intellectual and / or neurocognitive disability that the MHP deems a barrier to participation
- Any participant, who at the discretion of the MHP, should not be enrolled
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Case
Any person receiving services from a mental health provider who is able to either consent or for whom parental consent is able to be obtained.
|
Participants are asked a series of questions to elicit their feelings and emotions as part of an audio recorded interview along with their normal therapy session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Detection of Mental Health State
Time Frame: 1 year
|
Optimize machine learning models will detect the presence of a mental state as evidenced by scores on standardized tests and clinical assessment.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Demonstrate the Usability of the platform
Time Frame: 1 year
|
Demonstrate the usability of the MHSAFE recording platform and the dashboard output in different settings, including outpatient community mental health settings, schools (K-12), colleges/universities, and residential mental health facilities.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2020
Primary Completion (Estimated)
September 1, 2024
Study Completion (Estimated)
September 1, 2024
Study Registration Dates
First Submitted
July 15, 2020
First Submitted That Met QC Criteria
July 27, 2020
First Posted (Actual)
July 30, 2020
Study Record Updates
Last Update Posted (Actual)
February 6, 2024
Last Update Submitted That Met QC Criteria
February 5, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Clarigent 104-2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aggression
-
University of KonstanzCompletedAppetitive AggressionGermany
-
New York State Psychiatric InstituteCompletedIrritable AggressionUnited States
-
Boston UniversityU.S. Department of JusticeCompletedSexual Aggression | Offensive Aggression | Dating Violence Perpetration and VictimizationUnited States
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive AggressionUnited States
-
Weill Medical College of Cornell UniversityGreen Chimneys Residential Treatment Center, Brewster, NYCompletedChildhood AggressionUnited States
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Arizona State UniversityCompletedHeavy Drinking | Sexual AggressionUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive Aggression Comorbid With ADHDUnited Kingdom
-
Arizona State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State UniversityNot yet recruitingAlcohol Drinking | Sexual Behavior | Emotions | Sexual AggressionUnited States
-
Arizona State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State UniversityCompletedAlcohol Drinking | Sexual Behavior | Emotions | Sexual AggressionUnited States
Clinical Trials on MHSAFE app recording
-
Clarigent HealthChildren's Hospital Medical Center, Cincinnati; University of CincinnatiCompletedSuicide Ideation | Suicidal Intention | Suicide and DepressionUnited States
-
University of California, San FranciscoConquer Cancer FoundationActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Clarigent HealthXavier UniversityEnrolling by invitationDepression | Anxiety | Suicide | Mental Health IssueUnited States
-
University of California, San FranciscoNot yet recruiting
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHealthy VolunteersUnited States
-
University of UtahHuntsman Cancer InstituteTerminated
-
Centre d'Investigation Clinique et Technologique...National Research Agency, FranceCompletedAttitude to ComputersFrance
-
NewPace LtdCompletedArrhythmias, Cardiac | TachyarrhythmiaUnited States
-
Guy's and St Thomas' NHS Foundation TrustUniversity of Oxford; Engineering and Physical Sciences Research Council, UKCompleted
-
Rambam Health Care CampusUnknown